Andersons pediatric cardiology 2346
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (74.54 KB, 3 trang )
hemodynamicvariablesin,240–242,241b
inhepaticveins,244
historicalbackgroundin,237
ininferiorvenacava,244
ininternaljugularveins,244
inleftatrium,249
inleftventricle,250
inleftventricularoutflowtract,250
inmitralvalve,250
othercongenitalconsiderationsfor,251–252
potentialadverseeventsin,239
premedicationin,239
preprocedureconsiderationsfor,238
inpulmonaryarteries,247–248
inpulmonaryvalve,247
inpulmonaryvascularbed,248–249
inpulmonaryveins,249
qualitycontrolin,239
recommendationsfor,238–239
classI,238
classIIA,238
summaryof,238–239
inrightandleftinnominatevein,244,244f
inrightatrium,244–245
inrightventricle,246–247
inrightventricularoutflowtract,246–247
safetyin,239
sedationin,239
singleventricle/Fontanphysiologyin,251
insuperiorvenacava,244,245f
insystemicarteries,251
insystemicveins,243–244
intricuspidvalveapparatus,246
vascularaccessin,239
wiresfor,240
Diagnosticimaging,317–333
Diastolicdysfunction,indiagnosticcatheterization,250
Diastolicfunction,abnormalitiesof
cardiopulmonaryinteractionsin,1183
preservedsystolicfunctionwith,1179
Diastolicmaturation,developmentalchangesin,96
Diet,cardiovascularriskfactorsand,425
DiGeorge/velocardiofacialsyndrome,1410–1411,1411t
Digitalvolumepulse,1366,1366f
Digoxin
foratrialtachyarrhythmias,138,139t
forchronicheartfailure,1199
Dilatedcardiomyopathy(DC),1146b,1155–1159,1426
autosomaldominant,1155
cardiaccatheterizationin,1158
chestradiographyin,1157
clinicalfeaturesof,1157–1158
clinicaloutcomesof,1155,1156f
definitionof,1155
echocardiographyin,1157–1158,1158f
electrocardiographyin,1157,1157f
epidemiologyof,1155
etiologyof,1155–1156
exercisetestingin,1158
familial,1155
magneticresonanceimagingin,1158
managementof,1158–1159
pathologyof,1156,1156f
pathophysiologyof,1156–1157
X-linked,1156
Dilation,inKawasakidisease,983
Dinamapdevicesforbloodpressuremeasurement,1116
Directfetaltreatment,foratrialtachyarrhythmias,140
Directtoconsumertelemedicine,1556
Discharge
inFontanpathway,1295–1296
inKawasakisyndrome,993
planning,withteamprovidingcare,inambulatorysettingand“medicalhome,”,1487–1494
Disconnection,consequencesof,1488–1493
Discontinuationofdevices
ethicalconsiderationsindeterminingtimeof,1474
ethicalissuesand,1472–1474
Discontinuouspulmonaryarteries,indiagnosticcatheterization,248
Disharmonioussegmentalarrangements,congenitallycorrectedtransposition
and,701
Disposition,1429
Distalaortopulmonarywindow,fiftharcharteryversus,907–908,908f
Distensibility,arterialstiffnessand,1362t
Distribution,1429
Diuretics
forchronicheartfailure,1199
fordilatedcardiomyopathy,1158
forhemodynamicallysignificantarterialduct,198
forhypertension,1139–1140,1140t
Dividingcrest,86,86f
DNA,ofcardiomyocyte,67
Dobutamine
forhypotensionandcirculatorycollapse,inprematurity,204
stressechocardiographyusing,398
Donationaftercirculatorydeath(DCD),1476–1477
Dopamine
foracutecirculatoryfailure,1184t
